Related Experiment Video
Updated: Jul 23, 2026

Non-Terminal Blood Sampling Techniques in Guinea Pigs
Published on: October 11, 2014
Pathogenesis of Bolivian Hemorrhagic Fever in Guinea Pigs
T M Bell1, T E Bunton2, C I Shaia3
1US Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA todd.m.bell.mil@mail.mil.
Abstract:
Machupo virus, the cause of Bolivian hemorrhagic fever, is a highly lethal viral hemorrhagic fever with no Food and Drug Administration-approved vaccines or therapeutics. This study evaluated the guinea pig as a model using the Machupo virus-Chicava strain administered via aerosol challenge. Guinea pigs (Cavia porcellus) were serially sampled to evaluate the temporal progression of infection, gross and histologic lesions, and sequential changes in serum chemistry and hematology. The incubation period was 5 to 12 days, and complete blood counts revealed leukopenia with lymphopenia and thrombocytopenia. Gross pathologic findings included congestion and hemorrhage of the gastrointestinal mucosa and serosa, noncollapsing lungs with fluid exudation, enlarged lymph nodes, and progressive pallor and friability of the liver. Histologic lesions consisted of foci of degeneration and cell death in the haired skin, liver, pancreas, adrenal glands, lymph nodes, tongue, esophagus, salivary glands, renal pelvis, small intestine, and large intestine. Lymphohistiocytic interstitial pneumonia was also present. Inflammation within the central nervous system, interpreted as nonsuppurative encephalitis, was histologically apparent approximately 16 days postexposure and was generally progressive. Macrophages in the tracheobronchial lymph node, on day 5 postexposure, were the first cells to demonstrate visible viral antigen. Viral antigen was detected throughout the lymphoid system by day 9 postexposure, followed by prominent spread within epithelial tissues and then brain. This study provides insight into the course of Machupo virus infection and supports the utility of guinea pigs as an additional animal model for vaccine and therapeutic development.
Insights
This study shows guinea pigs are a viable model for Machupo virus, the cause of Bolivian hemorrhagic fever. Findings detail the disease progression and support using this model for developing new Machupo virus vaccines and therapeutics.
Area of Science:
- Virology
- Infectious Diseases
- Animal Models
Background:
- Machupo virus causes lethal Bolivian hemorrhagic fever.
- No FDA-approved vaccines or therapeutics currently exist.
- Need for effective animal models for research.
Purpose of the Study:
- Evaluate guinea pigs as a model for Machupo virus infection.
- Characterize the temporal progression of Machupo virus disease.
- Assess the utility of guinea pigs for vaccine and therapeutic development.
Main Methods:
- Aerosol challenge of guinea pigs with Machupo virus (Chicava strain).
- Serial sampling for hematology, serum chemistry, and gross/histologic pathology.
- Immunohistochemistry to detect viral antigen distribution.
Main Results:
- Incubation period of 5-12 days; observed leukopenia, lymphopenia, thrombocytopenia.
- Pathologic findings included GI hemorrhage, lung exudation, enlarged lymph nodes, liver changes, and encephalitis.
- Viral antigen detected in lymphoid tissues, epithelial tissues, and brain.
Conclusions:
- Guinea pigs exhibit a progressive, multi-organ disease course following Machupo virus infection.
- The observed pathology and viral spread support guinea pigs as a relevant model.
- This model can aid in the development of Machupo virus countermeasures.

